GSK3A and malignant colon neoplasm: To further confirm the clinical significance of GSK3α, we next performed immunohistochemical straining of colon cancer tissue microarrays from another independent colon cancer cohort using a specific anti-GSK3α antibody (supplemental Fig. S3, A and B and supplemental Table S2).